Pharmacology & ToxicologyMetabolismPeer-reviewed
PPARalpha-ERRalpha crosstalk mitigates metabolic dysfunction-associated steatotic liver disease progression
Milton Boaheng Antwi, Sander Lefere, Dorien Clarisse…·Karolien De Bosscher
This study shows that targeting PPAR and ERR receptors reduces liver fat, fibrosis, and inflammation in MASLD models, suggesting a new therapeutic strategy.
17 citationstop 3%